Search Results - "Wada, Yudai"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    N-Acetylcysteine Attenuates the Anxiety-Like Behavior and Spatial Cognition Impairment Induced by Doxorubicin and Cyclophosphamide Combination Treatment in Rats by Kitamura, Yoshihisa, Ushio, Soichiro, Sumiyoshi, Yusuke, Wada, Yudai, Miyazaki, Ikuko, Asanuma, Masato, Sendo, Toshiaki

    Published in Pharmacology (01-05-2021)
    “…Cancer patients can suffer from psychological and cognitive disorders after chemotherapy, which influence quality of life. Oxidative stress may contribute to…”
    Get more information
    Journal Article
  2. 2

    Effect of Lipopolysaccharide on the Duration of Zolpidem-Induced Loss of Righting Reflex in Mice by Wada, Yudai, Ushio, Soichiro, Kitamura, Yoshihisa, Zamami, Yoshito, Sendo, Toshiaki

    Published in Acta medica Okayama (01-06-2024)
    “…Zolpidem, a non-benzodiazepine hypnotic, is primarily used to treat insomnia. In a previous study, pior treatment with non-benzodiazepine receptor agonists was…”
    Get full text
    Journal Article
  3. 3

    Influence of 5-HT2A receptor function on anxiety-like behavior induced by a combination treatment with doxorubicin and cyclophosphamide in rats by Tabuchi, Hironori, Kitamura, Yoshihisa, Ushio, Soichiro, Kan, Shiho, Wada, Yudai, Sumiyoshi, Yusuke, Izushi, Yasuhisa, Miyazaki, Ikuko, Asanuma, Masato, Sendo, Toshiaki

    Published in Psychopharmacology (01-12-2021)
    “…Anxiety-like behavior induced by a combination of doxorubicin and cyclophosphamide may be mediated by serotonin (5-HT) 2A receptor hyperactivity. The…”
    Get full text
    Journal Article
  4. 4

    Anxiolytic-like effects of hochuekkito in lipopolysaccharide-treated mice involve interleukin-6 inhibition by Ushio, Soichiro, Wada, Yudai, Nakamura, Mizuki, Matsumoto, Daiki, Hoshika, Kota, Shiromizu, Shoya, Iwata, Naohiro, Esumi, Satoru, Kajizono, Makoto, Kitamura, Yoshihisa, Sendo, Toshiaki

    Published in Frontiers in pharmacology (12-08-2022)
    “…Hochuekkito (HET) is a Kampo medicine used to treat postoperative and post-illness general malaise and decreased motivation. HET is known to regulate immunity…”
    Get full text
    Journal Article
  5. 5

    Development of an appropriate simple suspension method for valganciclovir medication by Masaoka, Yasuyuki, Kawasaki, Yoichi, Kikuoka, Ryo, Ogawa, Atsushi, Esumi, Satoru, Wada, Yudai, Ushio, Soichiro, Kitamura, Yoshihisa, Sendo, Toshiaki

    “…Valganciclovir (VGC) is essential for preventing cytomegalovirus infections after transplants in adult and pediatric patients. In pediatric patients, VGC…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    A Case of Disseminated Bone Marrow Carcinomatosis Arising from Breast Cancer for Which Paclitaxel and Bevacizumab Treatment Was Effective by Kamata, Arimichi, Hagiwara, Hideyuki, Koizumi, Masaki, Sarukawa, Hideki, Wada, Yudai, Miyamae, Taku, Abe, Yutaka, Takahashi, Kazuhiro, Kano, Tsunehisa, Natori, Joji, Uchiyama, Kiichiro

    Published in Gan to kagaku ryoho (01-01-2016)
    “…A 42-year-old woman visited our hospital with high fever and general malaise. A CT examination revealed that she had carcinoma of the left breast with axillary…”
    Get more information
    Journal Article
  9. 9

    A Case of Alternate-Day Treatment with S-1 in a Patient with Multiple Lung Metastases of Colon Cancer by Kamata, Arimichi, Kano, Tsunehisa, Hagiwara, Hideyuki, Sarukawa, Hideki, Wada, Yudai, Miyamae, Taku, Koizumi, Masaki, Takahashi, Kazuhiro, Abe, Yutaka, Natori, Joji, Uchiyama, Kiichiro

    Published in Gan to kagaku ryoho (01-03-2016)
    “…The recommended regimen for S-1 internal use is 4 weeks of daily medication and 2 weeks of drug holiday. However, we experience many cases where changing the…”
    Get more information
    Journal Article
  10. 10

    Bumetanide prevents diazepam-modified anxiety-like behavior in lipopolysaccharide-treated mice by Matsumoto, Daiki, Ushio, Soichiro, Wada, Yudai, Noda, Yukiko, Esumi, Satoru, Izushi, Yasuhisa, Kitamura, Yoshihisa, Sendo, Toshiaki

    Published in European journal of pharmacology (05-08-2021)
    “…Benzodiazepine receptor agonists are widely prescribed therapeutic agents that alter gamma-aminobutyric acid (GABA)A receptor activity and have anxiolytic…”
    Get full text
    Journal Article
  11. 11

    Influence of 5-HT.sub.2A receptor function on anxiety-like behavior induced by a combination treatment with doxorubicin and cyclophosphamide in rats by Tabuchi, Hironori, Kitamura, Yoshihisa, Ushio, Soichiro, Kan, Shiho, Wada, Yudai, Sumiyoshi, Yusuke, Izushi, Yasuhisa

    Published in Psychopharmacology (01-12-2021)
    “…Anxiety-like behavior induced by a combination of doxorubicin and cyclophosphamide may be mediated by serotonin (5-HT).sub.2A receptor hyperactivity. The…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Influence of 5-HT 2A receptor function on anxiety-like behavior induced by a combination treatment with doxorubicin and cyclophosphamide in rats by Tabuchi, Hironori, Kitamura, Yoshihisa, Ushio, Soichiro, Kan, Shiho, Wada, Yudai, Sumiyoshi, Yusuke, Izushi, Yasuhisa, Miyazaki, Ikuko, Asanuma, Masato, Sendo, Toshiaki

    Published in Psychopharmacology (Berlin, Germany) (01-12-2021)
    “…Anxiety-like behavior induced by a combination of doxorubicin and cyclophosphamide may be mediated by serotonin (5-HT) receptor hyperactivity. The anxiolytic…”
    Get full text
    Journal Article